Viking Therapeutics Inc’s recently made public that its Chief Financial Officer ZANTE GREG unloaded Company’s shares for reported $4.99 million on May 03 ’24. In the deal valued at $74.69 per share,66,756 shares were sold. As a result of this transaction, ZANTE GREG now holds 174,854 shares worth roughly $9.67 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mancini Marianna sold 281,425 shares, generating $22,136,474 in total proceeds. Upon selling the shares at $78.66, the Chief Operating Officer now owns 348,508 shares.
Before that, Lian Brian sold 45,000 shares. Viking Therapeutics Inc shares valued at $1,345,500 were divested by the President & CEO at a price of $29.90 per share. As a result of the transaction, Lian Brian now holds 2,139,882 shares, worth roughly $118.38 million.
Morgan Stanley initiated its Viking Therapeutics Inc [VKTX] rating to an Overweight in a research note published on June 27, 2024; the price target was $105. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in mid May from “an Outperform” to “a Strong buy”. Oppenheimer also remained covering VKTX and reiterated its “an Outperform” recommendation on March 26, 2024. Jefferies started covering the stock on March 07, 2024. It rated VKTX as “a Buy”.
Price Performance Review of VKTX
On Monday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock jump 4.36% to $55.32. Over the last five days, the stock has gained 6.14%. Viking Therapeutics Inc shares have risen nearly 197.26% since the year began. Nevertheless, the stocks have risen 254.16% over the past one year. While a 52-week high of $99.41 was reached on 02/28/24, a 52-week low of $8.28 was recorded on 01/03/24. SMA at 50 days reached $63.47, while 200 days put it at $39.39. A total of 4.21 million shares were traded, compared to the trading of 16.15 million shares in the previous session.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 52.46, which if violated will result in even more drops to 49.60. On the upside, there is a resistance level at 58.22. A further resistance level may holdings at 61.12. The Relative Strength Index (RSI) on the 14-day chart is 48.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.49, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 24.20%. Stochastics%K at 59.69% indicates the stock is a holding.
The most recent change occurred on February 28, 2024 when Oppenheimer resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $116.
